# FDA Inspection 1017592 - Octapharma Plasma Inc - June 09, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/9dee9533-b32b-46d7-93e2-c7f43570e84d
Source feed: FDA_Inspections

> FDA Inspection 1017592 for Octapharma Plasma Inc on June 09, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1017592
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2017-06-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1252471 - 2025-01-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d09208bd-7467-4bb5-b74a-9c8a66456417)
- [FDA Inspection 1252471 - 2025-01-16](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5cf84eaf-8c40-4776-b282-2c8a91512d9e)
- [FDA Inspection 937941 - 2015-08-05](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/f312d5aa-eeda-4ca3-bd72-fb783120dc61)
- [FDA Inspection 827645 - 2013-04-12](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/5c17b9fe-0ce2-4c24-93d7-3432101ad0e3)
- [FDA Inspection 685909 - 2010-09-30](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/0b328cda-9d43-40b9-91c4-0a8caadff993)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/8d50af8d-62b1-493c-a055-124a81193e8b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d